SUBSCRIBE TO OUR RSS
SEARCH
Business
Finance
Health
Law/Policy
Tech/Innovation
font size
Sign in
Print
NEWS
The life sciences in the news
Home
|
Email
|
Print
|
[Please login to post comments]
Investors Weigh Biotech Results
Podcast: July 26, 2010
Read More
Reckitt Gets Its Mojo Rising
Life sciences deals and financings take a summer break.
Read More
Pfizer Halts Trial of Pain Drug
The weekly round-up of failed trials, missed targets and other business mishaps.
Read More
Gel is Promising in Preventing HIV Infections
South Africa may put it into use before regulators review it.
Read More
Clean Living
Cash rewards with counseling could help prevent STIs.
Read More
GAO Study Slams Direct-to-Consumer Genetic Test Companies
Stinging report comes as FDA interest in their products reaches a boil.
Read More
Recommendation Reversal
FDA panel says Avastin shouldn’t be marketed for breast cancer.
Read More
Mannkind Tries Again
Biopharma resubmits application for inhaled insulin to FDA.
Read More
Holding on to the Past
Reprogrammed adult stem cells may not be as versatile as first thought.
Read More
European Union Invests in Research and Innovation
Biggest ever funding package aims to stimulate smart growth and jobs.
Read More
Pfizer's Viagra Weighed by U.S. FDA for Children With Rare Lung Disorder
Bloomberg
New Health Official Faces Hostility in Senate
The New York Times
Pharma seeks FDA clarity on risky drug safeguards
Reuters
Special report: Targeting teens for gastric bands
Reuters
Genzyme Said to Rebuff Sanofi-Aventis Takeover Approach; Genzyme Advances
Bloomberg
Sanofi makes approach to Genzyme -sources
Reuters
Sanofi-Aventis’s Biotech Play for Genzyme
The New York Times
U.S. advisers reject Vivus fat-fighting pill
Reuters
PhRMA Names Business Roundtable's Castellani as CEO, Beginning Sept. 1
Bloomberg
Vivus' fat pill works; safety a concern-FDA staff
Reuters
» See more